EN DE
Watch PetVivo Holdings Inc for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

PetVivo Holdings Inc (PETV) fair value: what the stock is really worth

As of Nov 18, 2026: fair value (intrinsic value) of PetVivo Holdings Inc stock $0.33, price $0.26, upside +26.3%, quality 21 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · ISIN US7168174081

PH PetVivo Holdings Inc logo Thin data Nov 17, 2026

PetVivo Holdings Inc

PETV · US

The stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.

Follow free in the weekly email
Low debt 
Fair value $0.3304 · Fairly valued 
Mixed Growth (revenue 5y +146.4 %/yr in USD) 
Quality 21/100 
Falling price (downtrend) 
Negative free cash flow 
Trails peers (3/8) 
Narrow moat 12/100 · thin data
Thin data 
Estimate
Watch PetVivo Holdings Inc for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$9.20 $0.2615 Fair Value $0.3304 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.

How to read this chart

60‑month range $0.2615 – $9.20 · fair‑value band $0.2478 – $0.4130 · the $0.2615 price screens below the $0.3304 fair value. As of Nov 17, 2026.

Follow PetVivo Holdings in your weekly email

Every Wednesday you see whether PetVivo Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States.

Show moreShow less

The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications.

PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

Stock analysis

PetVivo Holdings Inc (PETV) currently trades at $0.2615, while our estimate is $0.3304, so the stock looks roughly fairly valued today (gap 20.8%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.2478 (bear) to $0.4130 (bull), the price of $0.2615 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 21/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

PetVivo Holdings Inc reported revenue of $1.1M in FY2026 versus $116K in FY2022, a compound +77.3%/yr. Reported net income was −$10.5M in FY2026.

Key figures

Market cap $10.0M Micro · P/S ratio 22.1 · EPS (TTM) $−0.3400 · Dividend yield 1.5% · Return on equity −384% · Return on assets (EBIT) −216% (5-year average) · Operating margin −477% · Revenue (TTM) $1.2M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).

What moves the price

The share trades about 80% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at 26%, PETV screens cheaper than that median.

Fair Value

Bear $0.2478 Fair Value $0.3304 Bull $0.4130
Price $0.2615 · Upside +26.3%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 21/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 11
How much profit the company makes from its sales and capital
Quality Growth 24
Are margins and returns getting better?
Cashflow 2
Do the profits arrive as real cash?
Financial strength 51
Debt, balance sheet and risk of trouble
Investment 44
Does it invest with discipline instead of growing at any price?
Low Volatility 18
How calm the share price moves, does not count
Price momentum 5
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

  • BuyA.L. Sarroff Fund, LLC10% owner6× since Mar 13, 2026: 1,848,990 shares, avg. $0.7000Oct 16, 2026

Plus 8 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 18, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 34/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+0.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+146.4%
Start year 2021 (pandemic). Over 10 years: +31.3% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−15,574.7% (2021) → −706.3% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

Watch PETV, get fair value alerts →

Compare PetVivo Holdings Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 400 stocks

Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 21 · Bottom 25%
Fair Value upside +26.3% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 13.5% · Above median
Dividend yield (12 months) 1.5% · Below median
Balance sheet
Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 4.57× · Priciest 25%
P/S (12 months) 8.50× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)68 · sector 19
FUTURE (revenue growth)68 · sector 43
PAST (return on equity)0 · sector 0
HEALTH (low debt)100 · sector 97
DIVIDEND (yield)31 · sector 34

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Boston Scientific Corporation BSX $43.64 $48.00 +10% vs PETV
DexCom, Inc DXCM $82.52 $90.77 +10% vs PETV
STERIS plc STE $259.57 $283.15 +9% vs PETV
Stryker Corporation SYK $318.15 $340.60 +7% vs PETV
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥184.80 ¥197.34 +7% vs PETV
GE HealthCare Technologies Inc GEHC $83.66 $69.92 −16% vs PETV
Edwards Lifesciences Corporation EW $105.23 $81.94 −22% vs PETV
Medtronic plc MDT $100.72 $74.89 −26% vs PETV
Abbott Laboratories, ABT $104.48 $75.28 −28% vs PETV
Koninklijke Philips N.V PHIA €26.77 €15.23 −43% vs PETV

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

PetVivo Holdings Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "PetVivo Holdings Inc Fair Value". https://www.fairvalue-calculator.com/stock/PETV

Frequently asked questions

Is PetVivo Holdings Inc (PETV) overvalued or undervalued?
As of Nov 17, 2026, our estimate of fair value is $0.3304 versus a price of $0.2615, about +26% upside (fairly valued).
What is the fair value of PETV?
Our estimate for PetVivo Holdings Inc is $0.3304 (as of Nov 17, 2026), built from audited fundamentals. The current price: $0.2615.
What is the quality score of PETV?
PetVivo Holdings Inc has a Quality Score of 21/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for PetVivo Holdings Inc (PETV)?
We do not set a price target; the yardstick is our estimate of $0.3304 (as of Nov 17, 2026). Cautious scenario $0.2478, optimistic scenario $0.4130. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the PetVivo Holdings Inc stock forecast for 2026?
Our estimate puts fair value at $0.3304, about +26% upside versus a price of $0.2615 (fairly valued). Cautious scenario $0.2478, optimistic scenario $0.4130. The calculation is refreshed regularly with new filings.
What is the revenue of PetVivo Holdings Inc (PETV)?
PetVivo Holdings Inc reported trailing-twelve-month revenue of about $1.2M (latest available figure, as of Nov 17, 2026).
Does PetVivo Holdings Inc pay a dividend?
PetVivo Holdings Inc currently shows a dividend yield of 1.54% relative to its recent price (as of Nov 17, 2026).
How much is the dividend of PetVivo Holdings Inc (PETV)?
PetVivo Holdings Inc has a dividend yield of 1.5%.
What is the intrinsic value of PetVivo Holdings Inc (PETV)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For PetVivo Holdings Inc it is $0.3304 per share (as of Nov 17, 2026), against a price of $0.2615.
Is PetVivo Holdings Inc stock overvalued or undervalued in 2026?
As of Nov 17, 2026, PETV trades below its calculated fair value: price $0.2615, fair value $0.3304, a gap of about +26% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PETV?
No. The price is what the market pays today ($0.2615); the fair value is what the company's own numbers justify ($0.3304). For PetVivo Holdings Inc the two are $0.0689 per share apart. That gap is exactly why we show both numbers side by side.
How much is PetVivo Holdings Inc worth?
The market values PetVivo Holdings Inc at about $10.0M (market capitalisation, as of Nov 17, 2026). Per share that is $0.2615; our models calculate a fair value of $0.3304 per share.
What do the bullish and bearish scenarios say about PETV?
Our models span a range for PetVivo Holdings Inc: cautious scenario $0.2478, base $0.3304, optimistic $0.4130 per share (as of Nov 17, 2026, price $0.2615). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of PetVivo Holdings Inc (PETV)?
Balance-sheet figures for PetVivo Holdings Inc (as of Nov 17, 2026): return on equity −384.4%, debt of 0.00 per unit of equity. They feed the Quality Score of 21/100, which measures business quality independently of the share price.
How far is PETV from its 52-week high?
PetVivo Holdings Inc trades at $0.2615, about 80% below its 52-week high of $1.28 and at the low of $0.2615 (as of Nov 18, 2026). Distance from the high says nothing about value: that is what the fair value of $0.3304 is for.
Which stocks are comparable to PetVivo Holdings Inc?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is PetVivo Holdings Inc stock attractive at the current price?
The data as of Nov 17, 2026: price $0.2615, calculated fair value $0.3304 (+26%), Quality Score 21/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 12.0% above its aggregate fair value. PetVivo Holdings Inc currently trades 21% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of PetVivo Holdings Inc (PETV)?
The closing price on Nov 18, 2026 was $0.2615. Our estimate is $0.3304, about +26% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with PetVivo Holdings Inc right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of PetVivo Holdings Inc

How large is the market capitalisation of PetVivo Holdings Inc (PETV)?
The market capitalisation of PetVivo Holdings Inc is $10.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of PetVivo Holdings Inc (PETV)?
The price-to-sales ratio of PetVivo Holdings Inc is 22.1 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of PetVivo Holdings Inc (PETV)?
Earnings per share at PetVivo Holdings Inc are $−0.3400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of PetVivo Holdings Inc (PETV)?
The dividend yield of PetVivo Holdings Inc is 1.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the return on equity of PetVivo Holdings Inc (PETV)?
The return on equity (ROE) of PetVivo Holdings Inc is −384% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of PetVivo Holdings Inc (PETV)?
On an EBIT basis the return on assets of PetVivo Holdings Inc is −216% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of PetVivo Holdings Inc (PETV)?
The operating margin of PetVivo Holdings Inc is −477% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at PetVivo Holdings Inc (PETV)?
Revenue at PetVivo Holdings Inc is growing 13.5% versus a year earlier (3y avg +7.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does PetVivo Holdings Inc (PETV) generate?
The free cash flow of PetVivo Holdings Inc is −$6.1M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does PetVivo Holdings Inc (PETV) carry?
The net debt of PetVivo Holdings Inc is $175K (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch PetVivo Holdings Inc in the live analysis

One click puts PetVivo Holdings Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.